DISCOUNT ZERTIFIKAT - AMGEN | Market Closed - Börse Stuttgart 20:19:37 27/05/2024 BST | ||
| 172.2 EUR | -0.25% |
|
| Current month | -0.94% | ||
| 1 month | -0.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/05/24 | 172.2 | -0.25% |
| 24/05/24 | 172.6 | -0.31% |
| 23/05/24 | 173.1 | +0.30% |
| 22/05/24 | 172.6 | +0.45% |
| 21/05/24 | 171.8 | -0.21% |
Delayed Quote Börse Stuttgart
Last update May 27, 2024 at 08:19 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680J |
| ISIN | DE000ME680J1 |
| Date issued | 02/01/2024 |
| Maturity | 20/09/2024 (116 Days) |
| Parity | 1 : 1 |
| Emission price | 167.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 174.3 € |
|---|---|
| Lowest since issue | 164.8 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
